// App-Quantinova.ai

: The Optimal Alternative Donor Transplant for Pediatric Patients with Acute Leukemia: A Comparison between Alfa-Beta T-Cell and B-Cell Depleted Haplo-SCT and UCBT

Researchers

Presenter

  • Franco Locatelli

Principal Investigators

  • Nicole Santoro

  • Jean-Hugues Dalle

  • Amal Al-Seraihy

  • Fernanda Volt

  • Mikhail Maschan

  • Charlotte Jubert

  • Marco Zecca

  • Eefke J. Petersen

  • Miguel ngel Daz Prez

  • Gerard Michel

  • Elena Skorobogatova

  • Cristina Daz de Heredia

  • Tracey OBrien

  • Chantal Kenzey

  • Vanderson Rocha

  • Eliane Gluckman

  • Peter Bader

  • Annalisa Ruggeri

Medical Centers

  • Department of Pediatric Hematology and Oncology , IRCCS Ospedale Bambino Gesu, Rome , Italy

  • Acute Leukemia Working Party of EBMT, Paris, France, Paris, France

  • Universita di Perugia, Perugia, Italy

  • Paediatric Disease Working Party of the European Society for Blood and Marrow Transplantation, Frankfurt, Germany

  • Pedaitric Rheumatology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

  • Centre Scientifique de Monaco, Monaco, Monaco

  • Department of Hematopoietic Stem Cell Transplantation №1, Dmitry Rogachev Federal Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

  • Hemato Pediatrics, CHU Bordeaux, Bordeaux Cedex, France

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Radiology, University Medical Center Utrecht, Utrecht

  • Department of Hematology, Hospital Niño Jesús, Madrid, Spain

  • Department of endocrinology, Aix Marseille University, Marseille, France

  • The Russian Children's Research Hospital, Moscow, Russian Federation

  • Servei d'Oncologia i Hematologia Pediàtriques,Hospital Universitari Vall d'Hebron,Barcelona,Spagna

  • UNSW Sydney, Sydney, Australia

  • Eurocord, Hopital Saint Louis APHP, University Paris-Diderot, Paris, France,

  • Department for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany

Locations

  • Italy

  • France

  • Saudi Arabia

  • Monaco

  • Russia

  • Spain

  • Australia

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

  • Tenascin-C

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

  • fludarabine tablet

  • Busulfan

  • Thiotepa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved